3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acetylcholinesterase activity and induces severe oxidative damage and liperoxidative damage

Biomedical and Environmental Sciences

Volumn 16, Issue 1, 2003, Pages 53-61

  Zhou, Jun Fu ^a,b   Zhou, Ye Hua ^c   Zhang, Liang ^c   Chen, Huai Hong ^a,b   Cai, Dong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Drug Abuse Surveillance Station   (China)

^c Hangzhou Public Security Bureau   (China)

Author keywords

3,4 Methylenedioxymethamphetamine; Acetylcholinesterase; Antioxidase; Drug abuse; Free radicals; Lipoperoxidative damage; Lipoperoxide; MDMA; Oxidative damage; Oxidative stress

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACETYLCHOLINESTERASE; CATALASE; CHOLINESTERASE INHIBITOR; LIPID PEROXIDE; SUPEROXIDE DISMUTASE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; DRUG ABUSE; DRUG EFFECT; ENZYMOLOGY; ERYTHROCYTE; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; METABOLISM; OXIDATIVE STRESS; URINE;

ACETYLCHOLINESTERASE; ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; CATALASE; CHOLINESTERASE INHIBITORS; ERYTHROCYTES; FEMALE; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 0042344717     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Shankaran, M., Yamamoto, B. K., and Gudelsky, G. A. (2001). Ascorbic acid prevents 3,4- methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT. Synapse 40, 55-64.
2. Cadet, J. L., Thiriet, N., and Jayanthi, S. (2001). Involvement of free radicals in MDMA-induced neurotoxicity in mice. Ann. Med. Interne. 152, Suppl. 3, IS 57-59.
3. Cadet, J. L., Ladenheim, B., Hirata, H., Rothman, R. B., Ali, S., Carlson, E., Epstein, C., and Moran, T. H. (1995). Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice. Synapse 21, 169-176.
4. Cerruti, C., Sheng, P., Ladenheim, B., Epstein, C. J., and Cadet, J. L. (1995). Involvement of oxidative and L-arginine-NO pathways in the neurotoxicity of drugs of abuse in vitro. Clin. Exp. Pharmacol. Physiol. 22, 381-382.
5. Kumagai, Y,. Lin, L. Y., Schmitz, D. A., and Cho, A. K. (1991). Hydroxyl radical mediated demethylenation of (methylenedioxy)phenyl compounds. Chem. Res. Toxicol. 4, 330-334.
6. Carvalho, M., Carvalho, F., and Bastos, M. L. (2001). Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4- methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes. Arch. Toxicol. 74, 789-793.
7. Beitia, G., Cobreros, A., Sainz, L., and Cenarruzabeitia, E. (2000). Ecstasy-induced toxicity in rat liver. Liver 20, 8-15.
8. Sprague, J. E. and Nichols, D. E. (1995). The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits. J. Pharmacol. Exp. Ther. 273, 667-673.
9. Esteban, B., O'Shea, E., Camarero, J., Sanchez, V., Green, A. R., and Colado, M. I. (2001). 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology (Berl) 154, 251-260.
10. Aguirre, N., Barrionuevo, M., Ramirez, M. J., Del-Rio, J., and Lasheras, B. (1999). Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity. Neuroreport 10, 3675-3680.
11. Colado, M. I., O'Shea, E., Esteban, B., Granados, R., and Green, A. R. (1999). In vivo evidence against clomethiazole being neuroprotective against MDMA ('ecstasy')-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism. Neuropharmacology 38. 307-314.
12. Colado, M. I., O'Shea, E., Granados, R., Esteban, B., Martin, A. B., and Green, A. R. (1999). Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4- methylenedioxymethamphetamine (MDMA or 'ecstasy') administration. Br. J. Pharmacol. 126, 911-924.
13. O'Shea, E., Granados, R., Esteban, B., Colado, M. I., and Green, A. R. (1998). The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 37, 919-926.
14. Sprague, J. E., Everman, S. L., and Nichols, D. E. (1998). An integrated hypothesis for the serotonergic axonal loss induced by 3,4- methylenedioxymethamphetamine. Neurotoxicology 19, 427-441.
15. Yeh, S. Y. (1997). Effects of salicylate on 3,4- methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats. Pharmacol. Biochem. Behav. 58, 701-708.
16. Colado, M. I., O'Shea, E., Granados, R., Misra, A., Murray, T. K., and Green, A. R. (1997). A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy. Br. J. Pharmacol. 121, 827-833.
17. Colado, M. I., O'Shea, E., Granados, R., Murray, T. K., and Green, A. R. (1997). In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine. Br. J. Pharmacol. 121, 889-900.
18. Colado, M. I. and Green, A. R. (1995). The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones. Eur. J. Pharmacol. 280, 343-346.
19. Cadet, J. L., Ladenheim, B., Baum, I., Carlson, E., and Epstein, C. (1994). CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxya-mphetamine (MDA) and of methylenedioxymethamphetamine (MDMA). Brain. Res. 655, 259-262.
20. Snodgrass, W. R. (1998). Clinical toxicology. In Casarett & Doull's Toxicology - the Basic Science of Poisons (Klaassen, C. D., Amdur, M. O., and Doull, J. Eds., 5th ed.), pp. 969-986. New York, McGraw-Hill Health Professions Division Press.
21. Ramos, K. S., Chacon, E., and Acosta, D. (1998). Toxic responses of the heart and vascular systems. In Casarett & Doull's Toxicology - the Basic Science of Poisons (Klaassen, C. D., Amdur, M. O., and Doull, J. Eds., 5th ed.), pp. 487-527. New York, McGraw-Hill Health Professions Division Press.
22. Thomas, J. A. (1998). Toxic responses of the reproductive system. In Casarett & Doull's Toxicology - the Basic Science of Poisons (Klaassen, C. D., Amdur, M. O., and Doull, J. Eds., 5th ed.), pp. 547-581. New York, McGraw-Hill Health Professions Division Press.
23. Gregus, Z. and Klaassen, C. D. (1998). Mechanisms of toxicity. In Casarett & Doull's Toxicology - the Basic Science of Poisons (Klaassen, C. D., Amdur, M. O., and Doull, J. Eds., 5th ed.), pp. 35-74. New York, McGraw-Hill Health Professions Division Press.
24. Parkinson, A. (1998). Biotransformation of xenobiotics. In Casarett & Doull's Toxicology - the Basic Science of Poisons (Klaassen, C. D., Amdur, M. O., and Doull, J. Eds., 5th ed.), pp. 113-186. New York, McGraw- Hill Health Professions Division Press.
25. Braitberg, G. and Kunkel, D. B. (1998). Amphetamines and amphetamine-like drugs. In Emergency Medicine - a Comprehensive Study Guide (Tintinalli, J. E., Ruiz, E., and Krome, R. L. Eds., 4th ed.), pp. 778-780. New York, McGraw-Hill Health Professions Division Press.
26. Lang, T. A. and Secic, M. (1997). How to Report Statistics in Medicine (1st ed.), pp. 65-80. Philadelphia, Port City Press.
27. Lwanga, S. K., Tye, C. H., and Ayeni, O. (1999). Teaching Health Statistics (2nd ed.), pp. 3-102. World Health Organization, Geneva.
28. Zhou, J. F., Yan, X. F., Guo, F. Z., Sun, N. Y., Qian, Z. J., and Ding, D. Y. (2000). Effects of cigarette smoking and smoking cessation on plasma constituents and enzyme activities related to oxidative stress. Biomed. Environ. Sci. 13, 44-55.
29. Zhou, J. F., Cai, D., Zhu, Y. G., Yang, J. L., Peng, C. H., and Yu, Y. H. (2000). A study on relationship of nitric oxide, oxidation, peroxidation, lipoperoxidation with chronic cholecystitis. World J. Gastroenterology 6, 501-507.
30. Zhou, J. F., Xu, G. B., and Fang, W. J. (2002). Relationship between acute organophosphorus pesticide poisoning and oxidative damages induced by free radicals. Biomed. Environ. Sci. 15, 177-186.
31. Xie, B., Zhou, J. F., Lu, Q., Li, C. J., and Chen, P. (2002). Oxidative stress in patients with acute coxsackie virus myocarditis. Biomed. Environ. Sci. 15, 48-57.
32. Chen, P. and Zhou J. F. (2001). Abnormal metabolism of nitric oxide, oxidative stress and lipoperoxidative stress in patients with acute viral myocarditis. Chinese Medical Journal 114, 1132-1135.
33. Chen, P. and Zhou, J. F. (2001). Changes of oxidative and lipoperoxidative metabolism in patients with acute viral myocarditis. Journal of Zhejiang University (SCIENCE) 2, 448-452.
34. Mayes, P. A. (2000). Biologic oxidation. In Harper's Biochemistry (Murray, R. K., Granner, D. K., Mayes, P. A., and Rodwell, V. W. Eds., 25th ed.), pp. 130-136. New York, McGraw-Hill Press.
35. Zhou, J. F., Yan, X. F., Ruan, Z. R., Peng, F. Y., Cai, D., Yuan, H., Sun, L., Ding, D. Y., and Xu, S. S. (2000). Heroin abuse and nitric oxide, oxidation, peroxidation, lipoperoxidation. Biomed. Environ. Sci. 13, 131-139.
36. Mayes, P. A. (2000). Lipids of physiologic significance. In Harper's Biochemistry (Murray, R. K., Granner, D. K., Mayes, P. A., and Rodwell, V. W. Eds., 25th ed.), pp. 160-171. New York, McGraw-Hill Press.
37. Zhou, J. F., Si, P. L., Ruan, Z. R., Ma, S. H., Yuan, H., Peng, F. Y., Sun, L., Ding, D. Y., and Xu, S. S. (2001). Primary studies on heroin abuse and injury induced by oxidation and lipoperoxidation. Chinese Medical Journal 114, 297-302.
38. Zhou, J. F., Chen, P., Yang, J. L., Zhu, Y. G., Peng, C. H., and Wu, Y. L. (2000). Oxidative stress before and after operation in patients with chronic cholecystitis containing gallstone. Biomed. Environ. Sci. 13, 254-262.
39. Murray, R. K. (2000). Muscle and the cytoskeleton. In Harper's Biochemistry (Murray, R. K., Granner, D. K., Mayes, P. A., and Rodwell, V. W. Eds., 25th ed.), pp. 715-736. New York, McGraw-Hill Press.
40. McKee, T. and McKee, J. R. (2000). Biochemistry: An introduction (2nd ed.), pp. 289-330. New York, McGraw-Hill Press.
41. Lingappa, V. R. and Farey, K. (2000). Physiological Medicine: A Clinical Approach to Basic Medical Physiology (1st ed.), pp. 25-30. New York, McGraw-Hill Press.
42. Thuraisingham, R. C. and Raine, A. E. G. (1998). Endocrine manifestations of systemic disease: the heart. In Clinical Endocrinology (Grossman, A. Eds., 2nd ed.), pp. 1077-1082. Victoria, Blackwell Science Ltd Press.
43. Zhou, J. F. and Chen, P. (2001). Studies on the oxidative stress in alcohol abusers in China. Biomed. Environ. Sci. 14, 180-188.
44. Chen, H. H. and Zhou, J. F. (2001). Low cholesterol in erythrocyte membranes and high lipoperoxides in erythrocytes are the potential risk factors for cerebral hemorrhagic stroke in human. Biomed. Environ. Sci. 14, 189-198.
45. Worek, F., Kirchner, T., Backer, M., and Szinicz, L. (1996). Reactivation by various oximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds. Arch. Toxicol. 70, 497-503.
46. Hahn, T., Ruhnke, M., and Luppa, H. (1991). Inhibition of acetylcholinesterase and butyrylcholinesterase by the organophosphorus insecticide methylparathion in the central nervous system of the golden hamster (Mesocricetus auratus). Acta. Histochem. 91, 13-19.